Investing with Charly AI
@charly___AI
Followers
374
Following
1K
Media
969
Statuses
2K
We spot opportunities before the crowd | Find multibaggers and make confident BUY, HOLD, or SELL decisions with Charly AI | https://t.co/wlT29yYwSl
Usa
Joined May 2024
Biotech Investing Without a PhD: CorMedix https://t.co/IPyL63PkUW
askcharly.ai
The Overlooked Phase in Biotech Investing
0
2
2
$LLY fundamentals are elite and momentum is undeniable, but the $NVDA pop stretches valuation even further. Great company, increasingly priced for perfection.
0
0
0
A growing number of investors are eyeing $TEM as one of the hottest AI-driven healthcare stocks on the market right now. Tempus AI focuses on applying artificial intelligence to precision medicine, using data and diagnostics to support clinical decisions. The company has rapidly
0
0
1
$MA is growing 17% year-over-year while already running a ~59% operating margin, which is rare. Despite this, the stock is more of a wait-and-see right now because it looks too expensive.
0
0
0
$NFLX dropped 27% in the past quarter as expectations were high, the valuation looked expensive, and selling accelerated once momentum weakened.
0
0
0
Who are the people buying $MSTR and why? I don't get it!!!
0
0
2
$GOOGL is now $4T market cap: 14% revenue growth year-to-date, 31% operating margins, fortress balance sheet. AI and Cloud spending lock in the future, but at this price, the upside looks mostly priced in. HOLD.
0
0
1
$TCOM is a strong setup: 16% year-over-year revenue growth, 30%+ operating margins, and a net-cash balance sheet, yet the stock still trades about 35% below fair value. The market hasn’t fully priced its earnings power.
0
0
1
$DUOL runs a high-margin growth engine. The stock dipped because patience isn’t a market feature.
0
0
2
$DAL is coming into earnings with strong results from last quarter, but the bar is set high. Here are the main things to keep an eye on. 1. Premium travel: Last quarter, Delta saw strong demand for premium seats and business travel. Investors will want to see if customers are
0
0
1
$DUO is growing revenue 40% YoY, running solid margins, sitting on $1B+ net cash and still trades ~30% undervalued!!!
0
1
2
$AXP Cash flow is strong, margins are steady, valuation is cheap; the math says BUY!!!
0
2
2
Now $PYPL is a better BUY vs $META $AMZN $AAPL $TSLA
0
1
1
$PYPL fundamentals are screaming BUY, but the chart is still doomscrolling.
0
1
2
Charly AI valuations are grounded on Prof. Aswath Damodaran’s data.
It is the end of the first full week of 2026, and as has been my practice every year for the last 33 years, I have updated the data on my webpage, reflecting the 2025 financial filings of publicly traded firms and updated market information.
0
1
1
$NXT acquired OnSight Technology . https://t.co/U6SZjvszFo. This solar farm monitoring robot service will definitely grow revenue. If you haven't read my bull case on $NXT
askcharly.ai
The NVIDIA of Power Infrastructure
0
1
1
$OPEN is a SELL: fundamentals are in bear mode while the stock price is living in an alternate universe.
0
0
0
I don’t get the excitement around $INTC, it remains a HOLD given foundry execution risk, strong competition, and a leveraged balance sheet.
0
0
0
$PYPL caught in a classic short-term noise, long-term signal paradox.
0
0
4